Recognising the potential of bio-regenerative therapies and technologies, the management team developed proprietary expertise and a unique operational service model to provide a range of therapeutic bio-regenerative services, targeting the wound care and aesthetic markets. This Biotherapy Services© BioTechnican Model©, is provided on a pay-per-case basis, directly supporting the specialist clinician, at point-of-care, and has been shown to accelerate technology adoption by optimising the effective delivery of the clinical condition-specific biotherapies, reducing risk and the investment requirements for specialist clinician users.
Biotherapy Services© was developed as a specialist operational model providing a range of biodynamic therapies to the clinicians and their patients as well as providing the services in specialist diabetic and complex wound care clinics.
Biotherapy Services Ltd., began as a small company focused on the introduction of innovative technologies in autologous cellular therapies, specifically focused on complex wound care and tissue regeneration in aesthetics and plastic and reconstructive surgery.
We acknowledged that in these dynamic and expanding markets, having the best technologies was not enough. The clinical adoption of these technologies and their e effective utilisation were based on 3 specific factors:
- UK based clinical studies to substantiate their safety and efficacy;
- A mechanism that provided the necessary expertise for a complex service to be delivered at point-of-care;
- Making it easy for the specialist clinician to introduce these biodynamic therapies into their clinical practice.
First, we set about establishing the clinical efficacy and were the best company to conduct clinical trials in the use of autologous PRP in aesthetics for skin rejuvenation; Nassab R., Matti B. et al (2012) BAAPS study into the use of PRP for skin rejuvenation.
Thereafter the Company funded and completed key clinical studies in wound care and these studies investigated the benefits of [different] platelet concentrations on wound healing. Two research projects were initiated:
MoD Queen Elizabeth II Hospital Birmingham Universities Foundation Trust treating young patients who had sustained life-changing trauma and had complex slow healing wounds. Wound healing was significantly shortened with the use of the proprietary PRP therapies, with a key case study achieving 79% wound closure in 13 days.
The RAPID Diabetic Foot Pilot Study conducted at Barts Health Foundation Trust – The Royal London Hospital, was completed September 2014, treating patients with severe diabetic wounds and at high risk of limb amputation. The results of the proprietary treatment resulted in preventing 26 out of 28 amputations.